Alij14, I intentionally ignore and dismiss the pos
Post# of 7769
The current p/s is likely a great entry point when we look back on it after the upcoming expected news comes out in the very near term, some of which would include:
Sept. revenues- early Oct
Oct revenues- early Nov
Q3 results- by Nov. 15th
RapiMeds - sometime in 2014, IMO and
Other pertinent facts and accomplishments-ongoing.
Plus:
Q4 results and 2014 results- once available.
We await great things ahead and the current p/s is a wise entry level IMHO. The ps/ s will be more reflective when these things fall into place and the news goes out. Meanwhile, I continue to look forward to the historic Q3, the rest of 2014 and beyond. Thanks.